Model-based analysis of treatment effects of paclitaxel microspheres in a microscopic peritoneal carcinomatosis model in mice
ConclusionsThe model predicts that the dose range of 7.5-15 mg/kg of PTXnano-GP-MS provides an optimal balance between efficacy and safety.
Source: Pharmaceutical Research - Category: Drugs & Pharmacology Source Type: research
More News: Abraxane | Cancer & Oncology | Carcinoma | Drugs & Pharmacology | Nanotechnology | Peritoneal Cancer | Toxicology